- Home
- BB vs LIVN Comparison
BB vs LIVN Comparison
Compare BB & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BB
- LIVN
- Stock Information
- Founded
- BB 1984
- LIVN 1987
- Country
- BB Canada
- LIVN United Kingdom
- Employees
- BB N/A
- LIVN N/A
- Industry
- BB
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BB
- LIVN Health Care
- Exchange
- BB Nasdaq
- LIVN Nasdaq
- Market Cap
- BB 2.2B
- LIVN 2.1B
- IPO Year
- BB 1997
- LIVN 1993
- Fundamental
- Price
- BB $4.01
- LIVN $54.53
- Analyst Decision
- BB Buy
- LIVN Strong Buy
- Analyst Count
- BB 6
- LIVN 7
- Target Price
- BB $4.64
- LIVN $59.71
- AVG Volume (30 Days)
- BB 5.9M
- LIVN 583.7K
- Earning Date
- BB 09-25-2025
- LIVN 10-29-2025
- Dividend Yield
- BB N/A
- LIVN N/A
- EPS Growth
- BB N/A
- LIVN N/A
- EPS
- BB N/A
- LIVN N/A
- Revenue
- BB $533,200,000.00
- LIVN $1,309,329,000.00
- Revenue This Year
- BB $2.17
- LIVN $11.29
- Revenue Next Year
- BB $7.03
- LIVN $6.59
- P/E Ratio
- BB N/A
- LIVN N/A
- Revenue Growth
- BB 4.65
- LIVN 8.23
- 52 Week Low
- BB $2.24
- LIVN $32.48
- 52 Week High
- BB $6.24
- LIVN $58.91
- Technical
- Relative Strength Index (RSI)
- BB 62.79
- LIVN 50.60
- Support Level
- BB $3.92
- LIVN $56.42
- Resistance Level
- BB $4.05
- LIVN $57.53
- Average True Range (ATR)
- BB 0.11
- LIVN 1.35
- MACD
- BB 0.03
- LIVN -0.70
- Stochastic Oscillator
- BB 84.21
- LIVN 10.25
About BB BlackBerry Limited
BlackBerry, once known for being the world's largest smartphone manufacturer, is now exclusively a software provider with a stated goal of end-to-end secure communications for enterprises. The firm provides endpoint management and other secure communications software to enterprises, specializing in regulated industries like government and financial institutions. BlackBerry also has a sizable embedded software business primarily serving the automotive market, with some exposure to the industrial market.
About LIVN LivaNova PLC
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.